These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
85 related articles for article (PubMed ID: 15861523)
21. Appropriate candidates for hemiablative focal therapy are infrequently encountered among men selected for radical prostatectomy in contemporary cohort. Tareen B; Sankin A; Godoy G; Temkin S; Lepor H; Taneja SS Urology; 2009 Feb; 73(2):351-4; discussion 354-5. PubMed ID: 19038430 [TBL] [Abstract][Full Text] [Related]
22. Limited value of perineural invasion in radical prostatectomy specimens as a predictor of biochemical recurrence in Japanese men with clinically localized prostate cancer. Miyake H; Sakai I; Harada K; Eto H; Hara I Hinyokika Kiyo; 2005 Apr; 51(4):241-6. PubMed ID: 15912782 [TBL] [Abstract][Full Text] [Related]
23. Easy method of assessing volume of prostate adenocarcinoma from estimated tumor area: using prostate tissue density to bridge gap between percentage involvement and tumor volume. Torlakovic G; Grover VK; Torlakovic E Croat Med J; 2005 Jun; 46(3):423-8. PubMed ID: 15861522 [TBL] [Abstract][Full Text] [Related]
24. Clinical relevance of the distribution of the lesions in 500 consecutive breast cancer cases documented in large-format histologic sections. Tot T Cancer; 2007 Dec; 110(11):2551-60. PubMed ID: 17932896 [TBL] [Abstract][Full Text] [Related]
25. Percent tumor involvement and risk of biochemical progression after radical prostatectomy. Rampersaud EN; Sun L; Moul JW; Madden J; Freedland SJ J Urol; 2008 Aug; 180(2):571-6; discussion 576. PubMed ID: 18554662 [TBL] [Abstract][Full Text] [Related]
26. [Survival after radical prostatectomy in patients with prostate cancer and seminal vesicle invasion]. Castillejos-Molina RA; RodrÃguez-Covarrubias F; Sotomayor de Zavaleta M; Uribe-Uribe N; Lino LS; Feria-Bernal G Rev Invest Clin; 2008; 60(5):360-4. PubMed ID: 19227432 [TBL] [Abstract][Full Text] [Related]
27. Tertiary Gleason pattern 5 is a powerful predictor of biochemical relapse in patients with Gleason score 7 prostatic adenocarcinoma. Hattab EM; Koch MO; Eble JN; Lin H; Cheng L J Urol; 2006 May; 175(5):1695-9; discussion 1699. PubMed ID: 16600733 [TBL] [Abstract][Full Text] [Related]
28. Preoperative MR imaging in the evaluation of seminal vesicle invasion in prostate cancer: pattern analysis of seminal vesicle lesions. Jung DC; Lee HJ; Kim SH; Choe GY; Lee SE J Magn Reson Imaging; 2008 Jul; 28(1):144-50. PubMed ID: 18500714 [TBL] [Abstract][Full Text] [Related]
29. Obesity and risk of biochemical progression following radical prostatectomy at a tertiary care referral center. Freedland SJ; Grubb KA; Yiu SK; Humphreys EB; Nielsen ME; Mangold LA; Isaacs WB; Partin AW J Urol; 2005 Sep; 174(3):919-22. PubMed ID: 16093988 [TBL] [Abstract][Full Text] [Related]
30. Association of prostate size and tumor grade in Korean men with clinically localized prostate cancer. Hong SK; Yu JH; Han BK; Chang IH; Jeong SJ; Byun SS; Lee HJ; Choe G; Lee SE Urology; 2007 Jul; 70(1):91-5. PubMed ID: 17656215 [TBL] [Abstract][Full Text] [Related]
33. Radial distance of extraprostatic extension measured by ocular micrometer is an independent predictor of prostate-specific antigen recurrence: A new proposal for the substaging of pT3a prostate cancer. Sung MT; Lin H; Koch MO; Davidson DD; Cheng L Am J Surg Pathol; 2007 Feb; 31(2):311-8. PubMed ID: 17255778 [TBL] [Abstract][Full Text] [Related]
34. The significance of positive surgical margin in areas of capsular incision in otherwise organ confined disease at radical prostatectomy. Chuang AY; Nielsen ME; Hernandez DJ; Walsh PC; Epstein JI J Urol; 2007 Oct; 178(4 Pt 1):1306-10. PubMed ID: 17698141 [TBL] [Abstract][Full Text] [Related]
35. Laterality alone should not drive selection of candidates for hemi-ablative focal therapy. Tareen B; Godoy G; Sankin A; Temkin S; Lepor H; Taneja SS J Urol; 2009 Mar; 181(3):1082-9; discussion 1089-90. PubMed ID: 19150090 [TBL] [Abstract][Full Text] [Related]
36. Prostate cancer disease-free survival after radical retropubic prostatectomy in patients older than 70 years compared to younger cohorts. Malaeb BS; Rashid HH; Lotan Y; Khoddami SM; Shariat SF; Sagalowsky AI; McConnell JD; Roehrborn CG; Koeneman KS Urol Oncol; 2007; 25(4):291-7. PubMed ID: 17628294 [TBL] [Abstract][Full Text] [Related]
37. Acute genitourinary toxicity after high-dose-rate (HDR) brachytherapy combined with hypofractionated external-beam radiation therapy for localized prostate cancer: correlation between the urethral dose in HDR brachytherapy and the severity of acute genitourinary toxicity. Akimoto T; Ito K; Saitoh J; Noda SE; Harashima K; Sakurai H; Nakayama Y; Yamamoto T; Suzuki K; Nakano T; Niibe H Int J Radiat Oncol Biol Phys; 2005 Oct; 63(2):463-71. PubMed ID: 16168838 [TBL] [Abstract][Full Text] [Related]
38. Impact of multiple biopsy cores on predicting final tumor volume in prostate cancer detected by a single microscopic focus of cancer on biopsy. Guzzo TJ; Vira M; Hwang WT; D'amico A; Tomaszewski J; Whittington R; Wein AJ; Vanarsdalen K; Malkowicz SB Urology; 2005 Aug; 66(2):361-5. PubMed ID: 16098364 [TBL] [Abstract][Full Text] [Related]
39. Pleomorphic giant cell adenocarcinoma of the prostate: report of 6 cases. Parwani AV; Herawi M; Epstein JI Am J Surg Pathol; 2006 Oct; 30(10):1254-9. PubMed ID: 17001156 [TBL] [Abstract][Full Text] [Related]
40. The independent impact of extended pattern biopsy on prostate cancer stage migration. Master VA; Chi T; Simko JP; Weinberg V; Carroll PR J Urol; 2005 Nov; 174(5):1789-93; discussion 1793. PubMed ID: 16217288 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]